FreMon Scientific

FreMon Scientific

Closed: Apr. 2022

About this raise

FreMon Scientific, with a valuation of $38.1 million, is raising funds on NetCapital. The company has developed, patented, and commercialized a blood product warming and thawing technology. The device is called ZipThaw202 with ZipSleeve and helps clinicians and lab technicians in plasma thawing. FreMon Scientific’s product is FDA cleared, certified under the American Association of Blood Banks, and sold in more than 14 countries and territories. Farideh Z. Bischoff, Frederick J. Thacher, and Menachem Shavit founded FreMon Scientific in April 2013. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1,069,996. The campaign proceeds will be used for compensation, sales and marketing, inventory, manufacturing, and product development.

Expand

Investment Overview

Not Funded: $0

Deal Terms

Total Commitments

Platform
Netcapital
Start Date
01/28/2022
Close Date
04/29/2022
Min. Goal
$10,008
Max Goal
$1,069,996
Min. Investment

$101

Security Type

Equity - Common

Company Stage

Growth Stage

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$11.27

Pre-Money Valuation

$38,190,807

Company & Team

Company

Year Founded
2013
Industry
Healthcare & Pharmaceuticals
Tech Sector
Medtech
Distribution Model
B2B
Margin
Low
Capital Intensity
High
Location
San Diego, California
Business Type
Growth
Company Website
Visit Website

Team

Employees
6
Prior Founder Exits?
No
Founder Name
Frederick Thatcher
Title
CDO & Director
Founder Name
Menachem Shavit
Title
CTO & Director

Funding data not publicly available

Financials

 Revenue
$225,814
 Monthly Burn
$389,469
 Runway
1.2 months

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$225,814

$0

COGS

$494,139

$0

Tax

$0

$0

 

 

Net Income

$-4,673,626

$-3,808,739

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$485,191

$1,607,641

Accounts Receivable

$0

$0

Total Assets

$2,772,353

$2,090,786

Short-Term Debt

$5,500,000

$0

Long-Term Debt

$2,349,579

$4,830,000

Total Liabilities

$7,849,579

$4,830,000

Create a free account today to gain access to Kingscrowd analytics and financials.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings Kingscrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars

Company Funding & Growth

Funding history

Close Date Platform Valuation Total Raised Security Type Status Reg Type
04/29/2022 Netcapital $38,190,807 $0 Equity - Common Not Funded RegCF
Create a free account today to gain access to Kingscrowd analytics.
Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
FreMon Scientific on Netcapital 2022
Platform: Netcapital
Security Type: Equity - Common
Valuation: $38,190,807
Price per Share: $11.27

Follow company

Follow FreMon Scientific on Netcapital 2022

Buy FreMon Scientific's Deal Report

Warning: according to the close date for this deal, FreMon Scientific may no longer be accepting investments.

FreMon Scientific Deal Report

Get Kingscrowd's comprehensive report on FreMon Scientific including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether FreMon Scientific is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the FreMon Scientific deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge